How much did SRTD Biotech raise?

SRTD Biotech raised €31.5M at Seed, announced 10 November 2026.

Who founded SRTD Biotech?

Matthias Alder is CEO of SRTD Biotech.

What does SRTD Biotech do?

SRTD Biotech operates in HealthTech and is based in Germany.

FundedStartupsDaily / HealthTech / SRTD Biotech

SRTD Biotech raises €31.5M

SRTD Biotech announced a Seed round of €31.5M on 10 November 2026. The company operates in HealthTech and is based in Germany. It was founded by Matthias Alder, CEO. Announced 3 days ago.

Raised

€31.5M

Stage

Seed

Industry

HealthTech

Country

Germany

Founder

Matthias Alder

CEO, SRTD Biotech

LinkedIn not availablesrtd-biotech.com

Outreach angles

-Matthias Alder was appointed CEO after the financing and previously held CEO, COO and CBO roles at publicly traded US and European biotech companies.
-SRTD was founded in 2019 at Forschungszentrum Julich by Dr. Bernd Hoffmann (now CSO) and Dr. Heribert Bohlen, and develops selectively expressed RNA (seRNA) that activates only in diseased cells.
-The EUR 31.5M oversubscribed seed led by Merieux Equity Partners, with NRW.BANK and Boehringer Ingelheim Venture Fund co-leading, will fund preclinical development toward an IND in oncology, autoimmune and fibrosis indications.